CALR and systemic lupus erythematosus: Regarding CLE, antinuclear antibodies (ANAs) were found in 54.3% patients and anti-SSA in 19.6%; as expected, anti-phospholipid antibodies were more frequently detected in SLE than in CLE patients (Table S1).